4.8 Article

A Mild PUM1 Mutation Is Associated with Adult-Onset Ataxia, whereas Haploinsufficiency Causes Developmental Delay and Seizures

期刊

CELL
卷 172, 期 5, 页码 924-+

出版社

CELL PRESS
DOI: 10.1016/j.cell.2018.02.006

关键词

-

资金

  1. Howard Hughes Medical Institute (HHMI)
  2. National Institute of Neurological Disorders and Stroke (NINDS) [2R37NS027699, NS091381]
  3. National Institute of General Medical Sciences [GM066099, GM079656]
  4. Robbins Foundation
  5. Joan and Stanford Alexander Family [CPRITRP160283]
  6. National Ataxia Foundation/Young Investigator Research Grant
  7. Neuroconnectivity Core at the NRI
  8. Eunice Kennedy Shriver National Institute of Child Health & Human Development
  9. Care4Rare Canada Consortium - Genome Canada
  10. Canadian Institute of Health Research
  11. Ontario Genomics Institute
  12. Ontario Research Fund
  13. Genome Quebec
  14. Children's Hospital of Eastern Ontario Foundation
  15. NHMRC post-graduate scholarship [GNT11149630]
  16. NHMRC CJ Martin Overseas Post-Doctoral Fellowship [GNT0512123]
  17. Toupin Foundation at the University of Alberta
  18. Baylor College of Medicine [IDDRC U54HD083092]

向作者/读者索取更多资源

Certain mutations can cause proteins to accumulate in neurons, leading to neurodegeneration. We recently showed, however, that upregulation of a wild-type protein, Ataxin1, caused by haploinsufficiency of its repressor, the RNA-binding protein Pumilio 1 (PUM1), also causes neurodegeneration in mice. We therefore searched for human patients with PUM1 mutations. We identified eleven individuals with either PUM1 deletions or de novo missense variants who suffer a developmental syndrome (Pumilio1-associated developmental disability, ataxia, and seizure; PADDAS). We also identified a milder missense mutation in a family with adult-onset ataxia with incomplete penetrance (Pumilio 1-related cerebellar ataxia, PRCA). Studies in patient-derived cells revealed that the missense mutations reduced PUM1 protein levels by similar to 25% in the adult-onset cases and by similar to 50% in the in it cases; levels of known PUM1 targets increased accordingly. Changes in protein levels thus track with phenotypic severity, and identifying posttranscriptional modulators of protein expression should identify new candidate disease genes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据